Inventor · disambiguated record
Herman H. Van Stuivenberg
Also filed as: VAN STUIVENBERG HERMAN H
17 granted patents·2 pending applications·81 citations·filing 1989–2009
90Inventor score
Top patents by PatentIndex Score
19 records- 0187US6974810B24,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activitySOLVAY PHARM BV·Filed 2002·Granted Dec 13, 2005·31 cites·9 claims
- 0282US7528162B24,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activitySOLVAY PHARM BV·Filed 2002·Granted May 5, 2009·20 cites·16 claims
- 0379US7319110B21H-1,2,4-triazole-3-carboxamide derivatives having cannabinoid-CB1 receptor agonistic, partial agonistic, inverse agonistic or antagonistic activitySOLVAY PHARM BV·Filed 2003·Granted Jan 15, 2008·14 cites·4 claims
- 0476US7608718B24,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activitySOLVAY PHARM BV·Filed 2005·Granted Oct 27, 2009·2 cites·2 claims
- 0570US7186741B2Neurotensin active 2,3,diaryl-pyrazolidine derivativesSOLVAY PHARM BV·Filed 2003·Granted Mar 6, 2007·6 cites·4 claims
- 0668US7851630B2Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptorsSOLVAY PHARM BV·Filed 2004·Granted Dec 14, 2010·4 cites·6 claims
- 0760US7495108B2Imidazoline derivatives having CB1-antagonistic activitySOLVAY PHARM BV·Filed 2007·Granted Feb 24, 2009·0 cites·5 claims
- 0857US7342032B2Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activitySOLVAY PHARMACEUTICALS INC·Filed 2003·Granted Mar 11, 2008·1 cites·9 claims
- 0956US8067603B2Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptorsHARTOG JACOBUS A J·Filed 2004·Granted Nov 29, 2011·2 cites·7 claims
- 1055US7498348B21 H-imidazole derivatives as cannabinoid receptor modulatorsSOLVAY PHARM BV·Filed 2007·Granted Mar 3, 2009·0 cites·3 claims
- 1155US7173044B2Imidazoline derivatives having CB1-antagonistic activitySOLVAY PHARM BV·Filed 2005·Granted Feb 6, 2007·0 cites·7 claims
- 1253US7271189B21H-imidazole derivatives as cannabinoid receptor modulatorsSOLVAY PHARM BV·Filed 2004·Granted Sep 18, 2007·0 cites·9 claims
- 1351US8729101B21H-imidazole derivative having CB1, agonistic, CB1 partial agonistic or CB1 antagnistic activityKRUSE CORNELIS G·Filed 2008·Granted May 20, 2014·0 cites·6 claims
- 1447US2004235854A11H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activityFiled 2002·Application pending·0 cites
- 1544US8937184B21H-imidazole derivatives as cannabinoid CB2 receptor modulatorsLANGE JOSEPHUS H M·Filed 2006·Granted Jan 20, 2015·0 cites·8 claims
- 1644US7745476B21,3,5-trisubstituted 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activitySOLVAY PHARM BV·Filed 2005·Granted Jun 29, 2010·0 cites·17 claims
- 1740US2011105523A1Bifeprunox derivativesVAN STUIVENBERG HERMAN H·Filed 2009·Application pending·0 cites
- 1837US4985423ANew 1,4-diazepine derivatives having anit-ulcer activityDUPHAR INT RES·Filed 1989·Granted Jan 15, 1991·1 cites·4 claims
- 1930US5140024A1,4-diazepine derivatives having anti-ulcer activityDUPHAR INT RES·Filed 1990·Granted Aug 18, 1992·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Herman H. Van Stuivenberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →